PDGF-D/PDGF-ββ receptor-regulated chemotaxis of malignant mesothelioma cells (Q39380409)

11 September 2017

title

PDGF-D/PDGF-ββ receptor-regulated chemotaxis of malignant mesothelioma cells (English)

1 reference

11 September 2017

1 reference

Asuka Okada

1 reference

11 September 2017

Takahiro Yaguchi

1 reference

11 September 2017

Takeshi Kanno

1 reference

11 September 2017

Akinobu Gotoh

1 reference

11 September 2017

Takashi Nakano

1 reference

11 September 2017

Tomoyuki Nishizaki

1 reference

11 September 2017

publication date

1 March 2012

1 reference

Cellular Physiology and Biochemistry

11 September 2017

published in

1 reference

11 September 2017

1 reference

11 September 2017

issue

1-2

1 reference

11 September 2017

page(s)

241-250

1 reference

Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches

11 September 2017

cites work

1 reference

Growth factors as active participants in carcinogenesis: a perspective

21 January 2018

1 reference

Serum PDGF-AB in pleural mesothelioma

21 January 2018

1 reference

ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells

21 January 2018

1 reference

Biology of platelet-derived growth factor and its involvement in disease

21 January 2018

1 reference

PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor

21 January 2018

1 reference

Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator.

21 January 2018

1 reference

A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression

21 January 2018

1 reference

Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells

21 January 2018

1 reference

Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent

21 January 2018

1 reference

Urinary trypsin inhibitor suppresses migration of malignant mesothelioma

21 January 2018

1 reference

The great escape: when cancer cells hijack the genes for chemotaxis and motility

21 January 2018

1 reference

Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed

21 January 2018

1 reference

Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets

21 January 2018

1 reference

Advances in the biology of malignant pleural mesothelioma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000337605

1 reference

11 September 2017

1 reference